- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04787874
Effect of Prehabilitation on Surgical Outcomes of Abdominally-based Plastic Surgery Procedures
Effect of Health Habits on Outcomes in Plastic and Reconstructive Surgery
Study Overview
Status
Intervention / Treatment
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Cara Black, PGY-2
- Phone Number: 650-723-7001
- Email: carablack@stanford.edu
Study Locations
-
-
California
-
San Jose, California, United States, 95124
- Recruiting
- Stanford Cancer Center South Bay
-
Contact:
- Rahim Nazerali, MD, MHS
-
Stanford, California, United States, 94304
- Recruiting
- Stanford Plastic and Reconstructive Surgery Clinic
-
Contact:
- Rahim Nazerali, MD, MHS
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Adult patients (>18 years) who are undergoing elective abdominally-based plastic surgery operations in 3+ weeks by one of the following plastic surgeons: Nazerali, Lee, Murphy, Nguyen, Lorenz.
Exclusion Criteria:
- Patients who do not speak English
- Patients who do not have access to a smartphone or internet/cell service.
- Patients who are undergoing another intervention study that consists of a nutrition and/or exercise behavior change.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: Control
The control arm will receive no additional prehabilitation material prior to material.
Rather, they will receive standard preoperative care in which they will be given standard advice on nutrition and fitness.
REDcap surveys will be administered.
|
|
|
Experimental: Prehab Intervention Arm
The intervention arm will receive access to the prehab program (abdominal workout videos) and surveys via RedCAP.The program will start no less than 14 days before the date of surgery.
|
Nutrition component: Participants will receive information on how to follow a healthy diet (Mediterranean-style diet) with emphasis on whole foods, plants, lean protein, olive oil; restriction of red meats, processed meats, processed foods, added sugar) Exercise component: Participants will receive an activity tracker to use during the study period (3+ weeks before surgery, and 30 days after surgery). Participants will be assigned strength exercises to work on core strength and proximal muscle strength (biceps/triceps, quads, hamstrings, calves).The exercises will mainly be focused on strengthening the abdominal wall. Exercises will be tailored to patients' individual capabilities. They will also be assigned cardio exercises - either low-intensity steady state cardio vs High Intensity Interval training. Level of cardio exercise will be tailored based on patient's Duke Activity score and baseline activity. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Occurrence of surgical complications (Post-op days 7-14)
Time Frame: Post-operative days 7-14
|
Will analyze the occurrence of surgical complications after surgery.
Hematoma, seroma, or abscess.
|
Post-operative days 7-14
|
|
Occurrence of surgical complications (Post-op day 30)
Time Frame: Post-operative day 30
|
Will analyze the occurrence of surgical complications after surgery.
Hematoma, seroma, or abscess.
|
Post-operative day 30
|
|
Occurrence of surgical complications (Post-op day 90)
Time Frame: Post-operative day 90
|
Will analyze the occurrence of surgical complications after surgery.
Hematoma, seroma, or abscess.
|
Post-operative day 90
|
|
Occurrence of surgical complications (Post-op day 180)
Time Frame: Post-operative day 180
|
Will analyze the occurrence of surgical complications after surgery.
Hematoma, seroma, or abscess.
|
Post-operative day 180
|
|
Occurrence of surgical complications (Post-op day 360)
Time Frame: Post-operative day 360
|
Will analyze the occurrence of surgical complications after surgery.
Hematoma, seroma, or abscess.
|
Post-operative day 360
|
|
Patient-Reported Outcome Measures: RAND 36-Item Health Survey (RAND-36) on Post-op days 7-14
Time Frame: Post-operative days 7-14
|
Will use the RAND 36-Item Health Survey (RAND-36) to assess the patient's perceived health following their surgical procedure.
The score for RAND-36 ranges from 0-100, having higher scores mean better outcomes.
|
Post-operative days 7-14
|
|
Patient-Reported Outcome Measures: Abdominal Surgery Impact Scale (ASIS) on Post-op days 7-14
Time Frame: Post-operative days 7-14
|
Will use the Abdominal Surgery Impact Scale (ASIS) to assess the patient's perceived health following their surgical procedure.
The ASIS score ranges from 18-126, having higher scores indicate better quality of life.
|
Post-operative days 7-14
|
|
Patient-Reported Outcome Measures: RAND 36-Item Health Survey (RAND-36) on Post-op day 30
Time Frame: Post-operative day 30
|
Will use the RAND 36-Item Health Survey (RAND-36) to assess the patient's perceived health following their surgical procedure.
The score for RAND-36 ranges from 0-100, having higher scores mean better outcomes.
|
Post-operative day 30
|
|
Patient-Reported Outcome Measures: Abdominal Surgery Impact Scale (ASIS) on Post-op day 30
Time Frame: Post-operative day 30
|
Will use the Abdominal Surgery Impact Scale (ASIS) to assess the patient's perceived health following their surgical procedure.
The ASIS score ranges from 18-126, having higher scores indicate better quality of life.
|
Post-operative day 30
|
|
Patient-Reported Outcome Measures: RAND 36-Item Health Survey (RAND-36) on Post-op day 90
Time Frame: Post-operative day 90
|
Will use the RAND 36-Item Health Survey (RAND-36) to assess the patient's perceived health following their surgical procedure.
The score for RAND-36 ranges from 0-100, having higher scores mean better outcomes.
|
Post-operative day 90
|
|
Patient-Reported Outcome Measures: Abdominal Surgery Impact Scale (ASIS) on Post-op day 90
Time Frame: Post-operative day 90
|
Will use the Abdominal Surgery Impact Scale (ASIS) to assess the patient's perceived health following their surgical procedure.
The ASIS score ranges from 18-126, having higher scores indicate better quality of life.
|
Post-operative day 90
|
|
Patient-Reported Outcome Measures: RAND 36-Item Health Survey (RAND-36) on Post-op day 180
Time Frame: Post-operative day 180
|
Will use the RAND 36-Item Health Survey (RAND-36) to assess the patient's perceived health following their surgical procedure.
The score for RAND-36 ranges from 0-100, having higher scores mean better outcomes.
|
Post-operative day 180
|
|
Patient-Reported Outcome Measures: Abdominal Surgery Impact Scale (ASIS) on Post-op day 180
Time Frame: Post-operative day 180
|
Will use the Abdominal Surgery Impact Scale (ASIS) to assess the patient's perceived health following their surgical procedure.
The ASIS score ranges from 18-126, having higher scores indicate better quality of life.
|
Post-operative day 180
|
|
Patient-Reported Outcome Measures: RAND 36-Item Health Survey (RAND-36) on Post-op day 360
Time Frame: Post-operative day 360
|
Will use the RAND 36-Item Health Survey (RAND-36) to assess the patient's perceived health following their surgical procedure.
The score for RAND-36 ranges from 0-100, having higher scores mean better outcomes.
|
Post-operative day 360
|
|
Patient-Reported Outcome Measures: Abdominal Surgery Impact Scale (ASIS) on Post-op day 360
Time Frame: Post-operative day 360
|
Will use the Abdominal Surgery Impact Scale (ASIS) to assess the patient's perceived health following their surgical procedure.
The ASIS score ranges from 18-126, having higher scores indicate better quality of life.
|
Post-operative day 360
|
|
Physical Function Test: 6-minute walk test at Time of Enrollment
Time Frame: Time of enrollment
|
Will use the 6-minute walk test.
The 6-minute walk test will be used to assess aerobic capacity and endurance.
A normal walk distance ranges from 400 to 700 m.
|
Time of enrollment
|
|
Physical Function Test: 5-times-sit-to-stand test at Time of Enrollment
Time Frame: Time of enrollment
|
Will use the 5-times-sit-to-stand test.
The 5-times-sit-to-stand test is a method to quantify functional lower extremity strength.
Lower times indicate better scores.
|
Time of enrollment
|
|
Physical Function Test: Timed-up-and-go test at Time of Enrollment
Time Frame: Time of enrollment
|
Will use the timed-up-and-go test.
The timed-up-and go test assesses one's mobility.
A lower score signifies better mobility.
|
Time of enrollment
|
|
Physical Function Test: 6-minute walk test at 3 weeks
Time Frame: 3 weeks
|
Will use the 6-minute walk test.
The 6-minute walk test will be used to assess aerobic capacity and endurance.
A normal walk distance ranges from 400 to 700 m.
|
3 weeks
|
|
Physical Function Test: 5-times-sit-to-stand test at 3 weeks
Time Frame: 3 weeks
|
Will use the 5-times-sit-to-stand test.
The 5-times-sit-to-stand test is a method to quantify functional lower extremity strength.
Lower times indicate better scores.
|
3 weeks
|
|
Physical Function Test: Timed-up-and-go test at 3 weeks
Time Frame: 3 weeks
|
Will use the timed-up-and-go test.
The timed-up-and go test assesses one's mobility.
A lower score signifies better mobility.
|
3 weeks
|
|
Physical Function Test: 6-minute walk test on Post-op Day 30
Time Frame: Post-operative day 30
|
Will use the 6-minute walk test.
The 6-minute walk test will be used to assess aerobic capacity and endurance.
A normal walk distance ranges from 400 to 700 m.
|
Post-operative day 30
|
|
Physical Function Test: 5-times-sit-to-stand-test on Post-op Day 30
Time Frame: Post-operative day 30
|
Will use the 5-times-sit-to-stand test.
The 5-times-sit-to-stand test is a method to quantify functional lower extremity strength.
Lower times indicate better scores.
|
Post-operative day 30
|
|
Physical Function Test: Timed-up-and-go test on Post-op Day 30
Time Frame: Post-operative day 30
|
Will use the timed-up-and-go test.
The timed-up-and go test assesses one's mobility.
A lower score signifies better mobility.
|
Post-operative day 30
|
|
Physical Function Test: 6-minute walk test on Post-op Day 90
Time Frame: Post-operative day 90
|
Will use the 6-minute walk test.
The 6-minute walk test will be used to assess aerobic capacity and endurance.
A normal walk distance ranges from 400 to 700 m.
|
Post-operative day 90
|
|
Physical Function Test: 5-times-sit-to-stand test on Post-op Day 90
Time Frame: Post-operative day 90
|
Will use the 5-times-sit-to-stand test.
The 5-times-sit-to-stand test is a method to quantify functional lower extremity strength.
Lower times indicate better scores.
|
Post-operative day 90
|
|
Physical Function Test: Timed-up-and-go test on Post-op Day 90
Time Frame: Post-operative day 90
|
Will use the timed-up-and-go test.
The timed-up-and go test assesses one's mobility.
A lower score signifies better mobility.
|
Post-operative day 90
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change from Baseline Albumin Levels at Time of Surgery
Time Frame: Enrollment to time of surgery
|
To analyze nutritional status
|
Enrollment to time of surgery
|
|
Change from Baseline Prealbumin Levels at Time of Surgery
Time Frame: Enrollment to time of surgery
|
To analyze nutritional status
|
Enrollment to time of surgery
|
|
Change from Baseline Transferrin Levels at Time of Surgery
Time Frame: Enrollment to time of surgery
|
To analyze nutritional status
|
Enrollment to time of surgery
|
|
Change from Baseline C-reactive Protein Levels at Time of Surgery
Time Frame: Enrollment to time of surgery
|
To analyze level of physiologic inflammation
|
Enrollment to time of surgery
|
|
Change from Baseline Erythrocyte Sedimentation Rates at Time of Surgery
Time Frame: Enrollment to time of surgery
|
To analyze level of physiologic inflammation
|
Enrollment to time of surgery
|
|
Change from Baseline Hemoglobin A1C Levels at Time of Surgery
Time Frame: Enrollment to time of surgery
|
To analyze degree of diabetes mellitus control
|
Enrollment to time of surgery
|
|
Change from Baseline Plasma Glucose Levels at Time of Surgery
Time Frame: Enrollment to time of surgery
|
To analyze degree of diabetes mellitus control
|
Enrollment to time of surgery
|
|
Change from Baseline White Blood Cell Count at Time of Surgery
Time Frame: Enrollment to time of surgery
|
Assessment for leukocytosis, anemia, renal disease; Part of the complete blood count.
|
Enrollment to time of surgery
|
|
Change from Baseline Hemoglobin Levels at Time of Surgery
Time Frame: Enrollment to time of surgery
|
Assessment for leukocytosis, anemia, renal disease; Part of the complete blood count.
|
Enrollment to time of surgery
|
|
Change from Baseline Hematocrit Levels at Time of Surgery
Time Frame: Enrollment to time of surgery
|
Assessment for leukocytosis, anemia, renal disease; Part of the complete blood count.
|
Enrollment to time of surgery
|
|
Change from Baseline Platelet Levels at Time of Surgery
Time Frame: Enrollment to time of surgery
|
Assessment for leukocytosis, anemia, renal disease; Part of the complete blood count.
|
Enrollment to time of surgery
|
|
Change from Baseline Chloride Levels at Time of Surgery
Time Frame: Enrollment to time of surgery
|
Assessment for leukocytosis, anemia, renal disease; Part of Basic Metabolic Panel
|
Enrollment to time of surgery
|
|
Change from Baseline Sodium Levels at Time of Surgery
Time Frame: Enrollment to time of surgery
|
Assessment for leukocytosis, anemia, renal disease; Part of Basic Metabolic Panel
|
Enrollment to time of surgery
|
|
Change from Baseline Potassium Levels at Time of Surgery
Time Frame: Enrollment to time of surgery
|
Assessment for leukocytosis, anemia, renal disease; Part of Basic Metabolic Panel
|
Enrollment to time of surgery
|
|
Change from Baseline Carbon Dioxide Levels at Time of Surgery
Time Frame: Enrollment to time of surgery
|
Assessment for leukocytosis, anemia, renal disease; Part of Basic Metabolic Panel
|
Enrollment to time of surgery
|
|
Change from Baseline Blood Urea Nitrogen Levels at Time of Surgery
Time Frame: Enrollment to time of surgery
|
Assessment for leukocytosis, anemia, renal disease; Part of Basic Metabolic Panel
|
Enrollment to time of surgery
|
|
Change from Baseline Creatinine Levels at Time of Surgery
Time Frame: Enrollment to time of surgery
|
Assessment for leukocytosis, anemia, renal disease; Part of Basic Metabolic Panel
|
Enrollment to time of surgery
|
|
Change from Baseline Blood Glucose Levels at Time of Surgery
Time Frame: Enrollment to time of surgery
|
Assessment for leukocytosis, anemia, renal disease; Part of Basic Metabolic Panel
|
Enrollment to time of surgery
|
Collaborators and Investigators
Sponsor
Investigators
- Study Director: Cindy Kin, MD, Asst Prof-Med Ctr Line
- Principal Investigator: Cara Black, MD, Resident
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 60419
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Ventral Hernia
-
Varazdin General HospitalCompletedIncisional Ventral Hernia | Recurrent Ventral HerniaCroatia
-
Anne Arundel Health System Research InstituteMedtronic - MITGCompletedGrade I Ventral Hernia | Grade II Ventral HerniaUnited States
-
Sofregen Medical, Inc.TerminatedVentral Hernia RepairUnited States
-
GSVM Medical CollegeCompleted
-
University Hospital, Strasbourg, FranceRecruitingVentral Hernia RepairFrance
-
Makassed General HospitalSuspended
-
Zaza DemetrashviliRecruitingLarge Midline Ventral HerniaGeorgia
-
Hvidovre University HospitalUniversity of CopenhagenCompleted
-
Hvidovre University HospitalCopenhagen University Hospital at HerlevCompleted
-
Distalmotion SAConfinisCompletedVentral Hernia RepairSwitzerland, Austria, France, Germany
Clinical Trials on Prehabilitation Program
-
FlevoziekenhuisActive, not recruitingExercise | Physical Fitness | Bariatric Surgery | Prehabilitation | Obesity and Overweight | Six Minute Walk TestNetherlands
-
Ain Shams UniversityCompletedCongenital Heart DiseaseEgypt
-
Institut Paoli-CalmettesNot yet recruiting
-
GERCOR - Multidisciplinary Oncology Cooperative...Active, not recruitingEsophageal Cancer | Pancreatic Ductal AdenocarcinomaFrance
-
Massachusetts General HospitalCompletedEsophageal Cancer | Esophageal NeoplasmsUnited States
-
Zealand University HospitalDanish Cancer Society; University Hospital Southampton NHS Foundation Trust; Region... and other collaboratorsActive, not recruiting
-
University of CologneDepartment of General, Visceral, Tumor and Transplant Surgery, University... and other collaboratorsCompletedTransthoracic EsophagectomyGermany
-
Ottawa Hospital Research InstituteUnknownCancer | FrailtyCanada
-
Université du Québec à Trois-RivièresFonds de soutien au démarrage de projets en collaboration (CSSSTR); Fonds pour...CompletedLumbar Spinal StenosisCanada
-
Sanford HealthUniversity of North DakotaActive, not recruitingCancer of Head and NeckUnited States